A Multicenter, Randomized, Double-blinded, Parallel, Placebo-controlled, Phase I/IIa Clinical Trial to Evaluate the Efficacy and Safety of Intra-articular YY1201 Once in the Treatment of Patients With Osteoarthritis of the Knee
Withdrawn prior to enrolment
Phase of Trial: Phase I/II
Latest Information Update: 19 Nov 2016
At a glance
- Drugs YY 1201 (Primary)
- Indications Osteoarthritis
- Focus Therapeutic Use
- Sponsors Yoo Young Pharmaceutical
- 02 Nov 2016 Planned End Date changed from 1 Sep 2016 to 1 Oct 2016.
- 02 Nov 2016 Planned primary completion date changed from 1 Mar 2016 to 1 Oct 2016.
- 02 Nov 2016 Status changed from recruiting to withdrawn prior to enrolment.